<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24214" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Leukocyte Adhesion Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Justiz Vaillant</surname>
            <given-names>Angel A.</given-names>
          </name>
          <aff>University of the West Indies</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmad</surname>
            <given-names>Faran</given-names>
          </name>
          <aff>Creighton University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Angel Justiz Vaillant declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faran Ahmad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24214.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Leukocyte adhesion deficiency (LAD) is an immunodeficiency disorder involving both B and T cells and is characterized by an inability of leukocytes to migrate to the site of infection to kill offending microbes. This activity describes the evaluation and management of leukocyte adhesion deficiency and reviews the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the different types of leukocyte adhesion deficiency defects in the etiology of leukocyte adhesion deficiency.</p></list-item><list-item><p>Identify the deficient integrins in the pathophysiology of leukocyte adhesion deficiency.</p></list-item><list-item><p>Summarize the immunological investigations used in the evaluation of leukocyte adhesion deficiency.</p></list-item><list-item><p>Outline the importance of collaboration and communication among the interprofessional team members to counsel and provide psychological support to the parents of a child with leukocyte adhesion deficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24214&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24214">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24214.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Leukocyte adhesion deficiency (LAD) is a defect of cellular adhesion molecules resulting in clinical syndromes. It is a combined (B cell) and cellular (T cell) immunodeficiency disorder.</p>
        <p>Major immunologic features<xref ref-type="bibr" rid="article-24214.r1">[1]</xref><xref ref-type="bibr" rid="article-24214.r2">[2]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>There is an inability to form pus.</p>
          </list-item>
          <list-item>
            <p>There is a deficiency of various glycoproteins, including LFA-1/Mac-1, glycoprotein 150/95.</p>
          </list-item>
          <list-item>
            <p>Leukocytes cannot migrate to infection sites to kill invading microorganisms due to mutations in the CD18 glycoprotein.</p>
          </list-item>
          <list-item>
            <p>Adhesion molecule deficiency results in an abnormal inflammatory response and eventually recurrent bacterial infections.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Primarily, leukocytes cannot escape from the blood to tissues that have been attacked by microbes. Continuous surveillance of foreign antigens by leukocyte trafficking suffers disruption as well. There are three different types of LAD<xref ref-type="bibr" rid="article-24214.r1">[1]</xref><xref ref-type="bibr" rid="article-24214.r3">[3]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I - in which steady adhesion of leukocyte to endothelial surfaces is defective by mutations in the CD18 gene resulting in defective or deficient beta-2 integrin</p>
          </list-item>
          <list-item>
            <p>Type II - in which there is an absence of Sialyl Lewis X of E-selectin</p>
          </list-item>
          <list-item>
            <p>Type III - in which there is a defect in kindlin-3; this impairs the integrin activation cascade - specifically, a mutation in the <italic toggle="yes">FERMT3</italic>&#x000a0;gene (11q13.1) causes this type of LAD</p>
          </list-item>
        </list>
        <p>LAD has an autosomal recessive mode of inheritance.</p>
        <list list-type="bullet">
          <list-item>
            <p>Seven new mutations in the ITGB2 gene reported, which encode the beta2 integrin family including three frameshift deletions (Tyr382fsX9, Asn282fsX41, and Lys636fsX22),&#x000a0;two splicing (IVS4-6C&#x0003e;A, IVS7+1G&#x0003e;A) and three missense (Asp128Tyr, Gly716Ala, and Ala239Thr).<xref ref-type="bibr" rid="article-24214.r4">[4]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Leukocyte&#x000a0;adhesion&#x000a0;deficiency&#x000a0;type-1 (LAD-I) is a rare, inherited combined deficiency disorder of the immune system; it affects 1 in 1 million people annually and frequently presents with recurrent, indolent bacterial infections.<xref ref-type="bibr" rid="article-24214.r5">[5]</xref></p>
        <p>The literature review of the clinical findings of patients with LAD-I reveals that recurrent infections (93.3%) and poor wound healing (86%) are the most prevalent clinical findings. A defect in CD18 (the beta subunit of the integrins) was present in all patients.<xref ref-type="bibr" rid="article-24214.r6">[6]</xref></p>
        <p>Mortality for severe leukocyte adhesion deficiency-I was reported as 75% by the age of 2 years (in an initial 1988 multicenter retrospective evaluation).&#x000a0;Patients with moderate disease&#x000a0; (2% to 30% CD18-expressing neutrophils) survive childhood with multiple infections affecting the skin and mucosal surfaces; documented mortality exceeds 50% by the age of 40 years.<xref ref-type="bibr" rid="article-24214.r7">[7]</xref></p>
      </sec>
      <sec id="article-24214.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Deficiency of the following integrins: LFA-1/Mac-1, p150, and p95 cause the immunologic and clinical abnormalities seen in leukocyte&#x000a0;adhesion&#x000a0;deficiency. These proteins function as adhesion molecules. They are present on lymphocytes, granulocytes, monocytes, and large granular lymphocytes. LFA-1, Mac-1, and glycoprotein 150/95 have a common beta chain but have distinct alpha chains denominated M1 (Mac-1 molecule), L1 (LFA-1 molecule), and X1 (p150,95 molecules). A defect in the beta subunit is accountable for the decreased expression of LFA-1/Mac-1 polypeptide. Natural killer cell activity is not affected. The lesion is on chromosome 21, noted in some patients studied by molecular biology techniques.<xref ref-type="bibr" rid="article-24214.r8">[8]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-24214.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Characteristically, a biopsy of infected tissue demonstrates inflammatory infiltrates completely devoid of neutrophils. Remnants of the umbilical cord can show a loose edematous tissue with remarkably few inflammatory cells. In contrast, there is an elevated level of peripheral blood leucocytes (over 29000/microliters) due to an impaired mobilization of leukocytes to extravascular sites of inflammation.<xref ref-type="bibr" rid="article-24214.r9">[9]</xref></p>
      </sec>
      <sec id="article-24214.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The classic presentation of leukocyte&#x000a0;adhesion&#x000a0;deficiency is recurrent bacterial infections, neutrophil adhesion defects, and umbilical cord sloughing delays. The adhesion defects result in poor leukocyte chemotaxis, particularly&#x000a0;the neutrophil, with an inability to form pus and neutrophilia.</p>
        <p>Individuals with leukocyte&#x000a0;adhesion&#x000a0;deficiency commonly suffer from bacterial infections beginning in the neonatal period. Infections such as omphalitis, pneumonia, gingivitis, and peritonitis are common and usually life-threatening due to the inability to destroy the invading pathogens. Individuals with LAD do not form abscesses because granulocytes cannot migrate to the sites of infection.</p>
        <p>Characteristics of patients with LAD include the following<xref ref-type="bibr" rid="article-24214.r6">[6]</xref><xref ref-type="bibr" rid="article-24214.r10">[10]</xref><xref ref-type="bibr" rid="article-24214.r11">[11]</xref>:</p>
        <p>LAD I:</p>
        <list list-type="bullet">
          <list-item>
            <p>Delayed separation of the umbilical cord</p>
          </list-item>
          <list-item>
            <p>Recurrent pyogenic infections, with onset in the first weeks of life</p>
          </list-item>
          <list-item>
            <p>Infections caused meanly by <italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;and <italic toggle="yes">Pseudomonas aeruginosa</italic></p>
          </list-item>
          <list-item>
            <p>Absent pus formation</p>
          </list-item>
          <list-item>
            <p>Periodontitis</p>
          </list-item>
        </list>
        <p>LAD II:</p>
        <list list-type="bullet">
          <list-item>
            <p>Recurrent skin infections</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis</p>
          </list-item>
          <list-item>
            <p>Tuberculosis &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Denture abnormalities</p>
          </list-item>
          <list-item>
            <p>Infections are less severe and fewer as compared to LAD I</p>
          </list-item>
        </list>
        <p>LAD III:</p>
        <list list-type="bullet">
          <list-item>
            <p>Omphalitis</p>
          </list-item>
          <list-item>
            <p>Osteoporosis like bone features</p>
          </list-item>
          <list-item>
            <p>Bleeding complications</p>
          </list-item>
          <list-item>
            <p>Hematological abnormalities, e.g., bone marrow failure</p>
          </list-item>
        </list>
        <p>Other miscellaneous manifestations may include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Vaginitis</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis</p>
          </list-item>
          <list-item>
            <p>Perianal abscesses&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Sinusitis</p>
          </list-item>
          <list-item>
            <p>Tracheobronchitis</p>
          </list-item>
          <list-item>
            <p>Necrotic soft tissue infections</p>
          </list-item>
          <list-item>
            <p>Otitis media</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Graft versus host reaction</p>
          </list-item>
          <list-item>
            <p>Recurrent tonsillitis</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Granuloma</p>
          </list-item>
          <list-item>
            <p>Oral candidiasis</p>
          </list-item>
          <list-item>
            <p>Aphthous stomatitis</p>
          </list-item>
          <list-item>
            <p>Urinary tract infections</p>
          </list-item>
          <list-item>
            <p>Lymphocytic interstitial pneumonitis</p>
          </list-item>
          <list-item>
            <p>Glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Hemolytic-uremic syndrome</p>
          </list-item>
          <list-item>
            <p>Nail dystrophy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Persistent hyperinsulinemic hypoglycemia of infancy</p>
          </list-item>
          <list-item>
            <p>Pyoderma gangrenosum</p>
          </list-item>
          <list-item>
            <p>Megakaryocytic acute myeloid leukemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The immunological investigation of a patient with leukocyte&#x000a0;adhesion&#x000a0;deficiency includes<xref ref-type="bibr" rid="article-24214.r12">[12]</xref><xref ref-type="bibr" rid="article-24214.r13">[13]</xref><xref ref-type="bibr" rid="article-24214.r7">[7]</xref>:</p>
        <p>
<bold>Flow Cytometry Analysis (definitive test):</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Demonstrates the absence of&#x000a0;functional CD18 and the associated alpha subunit molecules on the surface of leukocytes using CD11 and CD18 monoclonal antibodies (LAD I)</p>
          </list-item>
          <list-item>
            <p>Demonstrates the absence of sialyl Lewis X expression (CD15a) using a monoclonal antibody directed against sialyl Lewis X (LAD-II)</p>
          </list-item>
        </list>
        <p>
<bold>Sequence analysis using genetic testing.</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>To define the exact molecular defect in the beta-2 subunit</p>
          </list-item>
        </list>
        <p>
<bold>Quantitative Serum Immunoglobulins.</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG</p>
          </list-item>
          <list-item>
            <p>IgM</p>
          </list-item>
          <list-item>
            <p>IgA</p>
          </list-item>
          <list-item>
            <p>IgE</p>
          </list-item>
        </list>
        <p>
<bold>Antibody Activity.&#x000a0;</bold>
</p>
        <p>
<italic toggle="yes">IgG antibodies (post-immunization)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tetanus toxoid</p>
          </list-item>
          <list-item>
            <p>Diphtheria toxoid</p>
          </list-item>
          <list-item>
            <p>Pneumococcal polysaccharide</p>
          </list-item>
          <list-item>
            <p>Polio</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">IgG antibodies (post-exposure)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rubella</p>
          </list-item>
          <list-item>
            <p>Measles</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Varicella zoster</italic>
</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Detection of isohemagglutinins (IgM)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anti-type A blood</p>
          </list-item>
          <list-item>
            <p>Anti-type B blood</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Other assays</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Test for&#x000a0;heterophile antibody</p>
          </list-item>
          <list-item>
            <p>Anti-streptolysin O titer</p>
          </list-item>
          <list-item>
            <p>Immunodiagnosis of infectious diseases (HIV, hepatitis B and C, HTLV, and dengue)</p>
          </list-item>
          <list-item>
            <p>Serum protein electrophoresis</p>
          </list-item>
        </list>
        <p>
<bold>Blood lymphocyte subpopulations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Total lymphocyte count</p>
          </list-item>
          <list-item>
            <p>T lymphocytes (CD3, CD4, and CD8)</p>
          </list-item>
          <list-item>
            <p>B lymphocytes (CD19 and CD20)</p>
          </list-item>
          <list-item>
            <p>CD4/CD8 ratio</p>
          </list-item>
        </list>
        <p>
<bold>Lymphocyte stimulation assays</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Phorbol ester and ionophore</p>
          </list-item>
          <list-item>
            <p>Phytohemagglutinin</p>
          </list-item>
          <list-item>
            <p>Antiserum to CD3</p>
          </list-item>
          <list-item>
            <p>Chemotaxis of human lymphocytes</p>
          </list-item>
        </list>
        <p><bold>Phagocytic function</bold>&#x000a0;&#x000a0;</p>
        <p>
<italic toggle="yes">Nitroblue tetrazolium (NBT) test (before and after stimulation with endotoxin)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Unstimulated</p>
          </list-item>
          <list-item>
            <p>Stimulated</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Neutrophil mobility</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In medium alone</p>
          </list-item>
          <list-item>
            <p>In the presence of chemoattractant</p>
          </list-item>
          <list-item>
            <p>In vivo and in vitro chemotaxis of granulocytes</p>
          </list-item>
        </list>
        <p>
<bold>Complement System Evaluation</bold>
</p>
        <p>
<italic toggle="yes">Measurement of individual components by immunoprecipitation tests, ELISA, or Western blotting</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>C3 serum levels</p>
          </list-item>
          <list-item>
            <p>C4 serum levels</p>
          </list-item>
          <list-item>
            <p>Factor B serum levels&#x000a0;</p>
          </list-item>
          <list-item>
            <p>C1 inhibitor serum levels</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Hemolytic assays</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>CH50</p>
          </list-item>
          <list-item>
            <p>CH100</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Complement system functional studies</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Classical pathway assay (using IgM on a microtiter plate)</p>
          </list-item>
          <list-item>
            <p>Alternative pathway assay (using LPS on a microtiter plate)</p>
          </list-item>
          <list-item>
            <p>Mannose pathway assay (using mannose on a microtiter plate)&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Microbiological studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nasopharyngeal swab (testing for Rhinovirus)</p>
          </list-item>
          <list-item>
            <p>Stool (testing for viral, bacterial, or parasitic infection)</p>
          </list-item>
          <list-item>
            <p>Sputum (bacterial culture and pneumocystis PCR)</p>
          </list-item>
          <list-item>
            <p>Blood (bacterial culture, HIV by PCR, HTLV testing)</p>
          </list-item>
          <list-item>
            <p>Urine (testing for cytomegalovirus and proteinuria)</p>
          </list-item>
          <list-item>
            <p>Cerebrospinal fluid (culture, chemistry, and histopathology)</p>
          </list-item>
        </list>
        <p><bold>Other investigations of immunodeficiency disorders</bold>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Bone marrow biopsy</p>
          </list-item>
          <list-item>
            <p>Complete blood cell count &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Blood chemistry</p>
          </list-item>
          <list-item>
            <p>Histopathological studies</p>
          </list-item>
          <list-item>
            <p>Tumoral markers</p>
          </list-item>
          <list-item>
            <p>Levels of cytokines</p>
          </list-item>
          <list-item>
            <p>Chest x-ray</p>
          </list-item>
          <list-item>
            <p>Diagnostic&#x000a0;ultrasound</p>
          </list-item>
          <list-item>
            <p>Liver function test</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <list list-type="bullet">
          <list-item>
            <p>The treatment of LAD-I is an allogeneic hematopoietic stem cell transplant (HSCT). By the age of 2 years, the disease is fatal in severe cases without HSCT.<xref ref-type="bibr" rid="article-24214.r7">[7]</xref><xref ref-type="bibr" rid="article-24214.r14">[14]</xref><xref ref-type="bibr" rid="article-24214.r7">[7]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ustekinumab, a monoclonal antibody of the p40 subunit common to IL-12 and IL-23, had been used successfully to treat refractory periodontitis and sacral ulcer in a case report with mild LAD I.<xref ref-type="bibr" rid="article-24214.r15">[15]</xref> However, further studies are necessary to determine safety and efficacy, particularly in patients with more severe disease.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recombinant human interferon-gamma treatment has been used in LAD-I.&#x000a0;<xref ref-type="bibr" rid="article-24214.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>A trial of fucose supplementation is recommended in all patients diagnosed with LAD II<xref ref-type="bibr" rid="article-24214.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Recombinant factor VIIa is considered effective in treating and preventing severe bleeding in a child patient with LAD III&#x000a0;<xref ref-type="bibr" rid="article-24214.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>The use of prophylactic immunoglobulin therapy was successful in two patients with a severe form of LAD.<xref ref-type="bibr" rid="article-24214.r19">[19]</xref>&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>More conservative treatment is directed against specific infectious agents. Patients are infected with common pathogenic agents but not with opportunistic ones and should respond well to antimicrobial therapy. The most common pathogens affecting patients with LAD include <italic toggle="yes">Proteus</italic>, <italic toggle="yes">Klebsiella</italic>, <italic toggle="yes">Staphylococcus aureus, Pseudomonas aeruginosa</italic>, and enterococci.&#x000a0; Early aggressive treatment should be used or given as prophylactic therapy (e.g., dental procedures).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differentials for leukocyte&#x000a0;adhesion&#x000a0;deficiency include the following list of disorders<xref ref-type="bibr" rid="article-24214.r20">[20]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bare lymphocyte syndrome&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic granulomatous disease</p>
          </list-item>
          <list-item>
            <p>Chediak-Higashi syndrome&#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hyper IgE syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>All of these immunological disorders have abnormal chemotaxis and/or abnormal respiratory burst activity but can be differentiated clinically by immunohistochemistry and molecular biology techniques</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24214.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The leukocyte&#x000a0;adhesion&#x000a0;deficiency prognosis varies depending on the severity of the disease; it is usually fatal before one year of age. Moderate LAD cases can live longer than the third decade of life with appropriate antimicrobial therapy. Those patients with successful allogeneic hematopoietic stem cell transplants can have a better quality of life.</p>
      </sec>
      <sec id="article-24214.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most common complications are infectious diseases affecting the skin, respiratory system, gastrointestinal system, oral cavity, and some internal organs. Leukocyte&#x000a0;adhesion&#x000a0;deficiency has a high mortality rate.</p>
      </sec>
      <sec id="article-24214.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Consanguineous couples with an affected child should be counseled about the likelihood of having another affected child. They should counsel about patient care in health and disease.&#x000a0;</p>
      </sec>
      <sec id="article-24214.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team should treat a patient with leukocyte adhesion deficiency comprised of a specialty-trained genetics nurse, pediatrician, geneticist, clinical immunologist, and infectious disease specialist. Parents of a child affected with leukocyte adhesion deficiency should receive counsel about the disease, and the integral management of the patient. Parents also require psychological support.</p>
      </sec>
      <sec id="article-24214.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24214&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24214">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/leukocyte-adhesion-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24214">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24214/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24214">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24214.s16">
        <title>References</title>
        <ref id="article-24214.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion deficiencies.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>1250</volume>
            <fpage>50</fpage>
            <page-range>50-5</page-range>
            <pub-id pub-id-type="pmid">22276660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niethammer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dieterle</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kleihauer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wildfeuer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haferkamp</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Hitzig</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>An inherited defect in granulocyte function: impaired chemotaxis, phagocytosis and intracellular killing of microorganisms.</article-title>
            <source>Helv Paediatr Acta</source>
            <year>1976</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>537</fpage>
            <page-range>537-41</page-range>
            <pub-id pub-id-type="pmid">1270326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stepensky</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Wolach</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gavrieli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rousso</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ben Ami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rozovsky</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2015</year>
            <month>May</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>264</fpage>
            <page-range>264-8</page-range>
            <pub-id pub-id-type="pmid">25072369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parvaneh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mamishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tamizifar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parvaneh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sherkat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ghalehbaghi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kashef</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chavoshzadeh</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Isaeian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ashrafi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene.</article-title>
            <source>J Clin Immunol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>756</fpage>
            <page-range>756-60</page-range>
            <pub-id pub-id-type="pmid">20549317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cox</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Weathers</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion deficiency type 1: an important consideration in the clinical differential diagnosis of prepubertal periodontitis. A case report and review of the literature.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>105</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-90</page-range>
            <pub-id pub-id-type="pmid">17618138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Movahedi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Entezari</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pourpak</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mamishi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chavoshzadeh</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gharagozlou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mir-Saeeid-Ghazi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fazlollahi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Zandieh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bemanian</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Farhoudi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases).</article-title>
            <source>J Clin Immunol</source>
            <year>2007</year>
            <month>May</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>302</fpage>
            <page-range>302-7</page-range>
            <pub-id pub-id-type="pmid">17294145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almarza Novoa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kasbekar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thrasher</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kohn</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Sevilla</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Bueren</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion deficiency-I: A comprehensive review of all published cases.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>1418</fpage>
            <page-range>1418-1420.e10</page-range>
            <pub-id pub-id-type="pmid">29371071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tokunaga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miyamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ohashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ishiwada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Terakura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ikeguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuwatsuka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuchiya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kodera</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor.</article-title>
            <source>Int J Hematol</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-5</page-range>
            <pub-id pub-id-type="pmid">17675274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nezelof</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chronic omphalitis in a 4-month-old girl.</article-title>
            <source>Pathol Res Pract</source>
            <year>1991</year>
            <month>Mar</month>
            <volume>187</volume>
            <issue>2-3</issue>
            <fpage>334</fpage>
            <page-range>334-7; discussion 337-40</page-range>
            <pub-id pub-id-type="pmid">2068017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r10">
          <label>10</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Qurie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Immunodeficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29763203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Atkinson</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Oral manifestations associated with leukocyte adhesion deficiency: a five-year case study.</article-title>
            <source>Pediatr Dent</source>
            <year>1990</year>
            <season>Apr-May</season>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-11</page-range>
            <pub-id pub-id-type="pmid">2133935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simpson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bohnsack</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Lamont</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Siddiqi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Gociman</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pyoderma Gangrenosum-like Wounds in Leukocyte Adhesion Deficiency: Case Report and Review of Literature.</article-title>
            <source>Plast Reconstr Surg Glob Open</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>e1886</fpage>
            <pub-id pub-id-type="pmid">30254829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion defect: An uncommon immunodeficiency.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <page-range>119-122</page-range>
            <pub-id pub-id-type="pmid">29371732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Le Deist</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cavazzana-Calvo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benkerrou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Blanche</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Friedrich</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency.</article-title>
            <source>Blood</source>
            <year>1995</year>
            <month>Aug</month>
            <day>15</day>
            <volume>86</volume>
            <issue>4</issue>
            <fpage>1629</fpage>
            <page-range>1629-35</page-range>
            <pub-id pub-id-type="pmid">7632973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moutsopoulos</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Zerbe</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wild</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dutzan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brenchley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>DiPasquale</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Uzel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Axelrod</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Lisco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Hajishengallis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Mar</month>
            <day>23</day>
            <volume>376</volume>
            <issue>12</issue>
            <fpage>1141</fpage>
            <page-range>1141-1146</page-range>
            <pub-id pub-id-type="pmid">28328326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weening</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bredius</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Vomberg</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>van der Schoot</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Hoogerwerf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Recombinant human interferon-gamma treatment in severe leucocyte adhesion deficiency.</article-title>
            <source>Eur J Pediatr</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>151</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-7</page-range>
            <pub-id pub-id-type="pmid">1537350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marquardt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000fc;hn</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Srikrishna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Freeze</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Harms</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vestweber</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Correction of leukocyte adhesion deficiency type II with oral fucose.</article-title>
            <source>Blood</source>
            <year>1999</year>
            <month>Dec</month>
            <day>15</day>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>3976</fpage>
            <page-range>3976-85</page-range>
            <pub-id pub-id-type="pmid">10590041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saultier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Szepetowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Canault</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Falaise</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Poggi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Suchon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barlogis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Loyau</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jandrot-Perrus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bordet</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Alessi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Chambost</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation.</article-title>
            <source>Haematologica</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>103</volume>
            <issue>6</issue>
            <fpage>e264</fpage>
            <page-range>e264-e267</page-range>
            <pub-id pub-id-type="pmid">29472353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamazaki-Nakashimada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maravillas-Montero</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Berr&#x000f3;n-Ruiz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Ortega</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez-Alejo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Acevedo-Ochoa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rivas-Larrauri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Llamas-Guill&#x000e9;n</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Blancas-Galicia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scheffler-Mendoza</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Olaya-Vargas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Santos-Argumedo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1).</article-title>
            <source>Immunol Res</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-8</page-range>
            <pub-id pub-id-type="pmid">25527966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24214.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naess</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sjursen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Leegaard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Leukocyte adhesion deficiency in a Norwegian boy.</article-title>
            <source>Scand J Infect Dis</source>
            <year>1999</year>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>600</fpage>
            <page-range>600-2</page-range>
            <pub-id pub-id-type="pmid">10680995</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
